Wikipedia -WSS

Wikipedia

author：entertainment 2025-10-01 04:10:02 - browse：73859

Drugmakers already bet big on mRNA for cancer. Now President Biden is going in, too? Anna Moneymaker/Getty Images

WASHINGTON — President Biden’s fledgling health agency, designed to accelerate under-funded research, just set its sights on one of the hottest areas of medicine — and one where the drug industry has a multibillion-dollar head start.

The White House announced Wednesday that the Advanced Research Projects Agency for Health would bankroll a $24 million project by Emory University to build messenger RNA platforms to target “cancer and other diseases,” investing in the technology behind the U.S.’s most commonly used vaccines for Covid-19.

The administration touted the news of CUREIT as the latest in Biden’s longtime mission to rein in cancer deaths, the Cancer Moonshot. But by using mRNA to treat cancer, ARPA-H is wading into a field that has advanced in fits and starts — and whose industry leaders have already spent multiples of the program’s entire budget into their own research. Moderna and BioNTech, massively profitable companies that have sold more than $80 billion worth of Covid-19 vaccines combined, have singled out oncology as the next big application for mRNA and invested accordingly.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Insmed lung disease drug hits target in key Phase 3 trial

focus

WSS

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Congress may force more Covid

Reporting on presidential health from Reagan to Trump and Biden

Health insurers say they are turning to AI to cut costs, improve care

MD Anderson's Padmanee Sharma responds to research credit suit

Hospitals are piloting generative AI tools as regulators play catch

focus

Wikipedia

hotspot

Affirmative action in medical school literally saved lives

Addiction doctors spar with methadone clinics over legislation

New air purifier tech could be key to improving indoor air quality

Antibiotic resistance nearly killed me, so I'm raising awareness of it

In age of alternative facts, a scholarly course on calling out crap

Heat waves linked to early deliveries, preterm births in new study

Alkermes shareholders re

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

What does generative AI mean for health care? We asked experts

David Sabatini, ex

leisure time

Do more moles mean more problems? Not so, says new study

As AI regulations shape up, health tech startups beg for clarity

Hospitals are piloting generative AI tools as regulators play catch

Insmed lung disease drug hits target in key Phase 3 trial

Congress may force more Covid

FDA warns medical device makers about rise in fabricated data

leisure time

focus

Wikipedia

entertainment